Jürgen Floege

40.4k total citations · 11 hit papers
412 papers, 21.0k citations indexed

About

Jürgen Floege is a scholar working on Nephrology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jürgen Floege has authored 412 papers receiving a total of 21.0k indexed citations (citations by other indexed papers that have themselves been cited), including 306 papers in Nephrology, 59 papers in Pathology and Forensic Medicine and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jürgen Floege's work include Renal Diseases and Glomerulopathies (174 papers), Chronic Kidney Disease and Diabetes (98 papers) and Parathyroid Disorders and Treatments (82 papers). Jürgen Floege is often cited by papers focused on Renal Diseases and Glomerulopathies (174 papers), Chronic Kidney Disease and Diabetes (98 papers) and Parathyroid Disorders and Treatments (82 papers). Jürgen Floege collaborates with scholars based in Germany, United States and United Kingdom. Jürgen Floege's co-authors include Peter Boor, Tammo Ostendorf, Markus Ketteler, Charles E. Alpers, Danilo Fliser, Frank Eitner, Richard J. Johnson, Willi Jahnen‐Dechent, Ralf Westenfeld and Nikolaus Marx and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jürgen Floege

400 papers receiving 20.6k citations

Hit Papers

Cardiovasc... 1992 2026 2003 2014 2021 2003 2003 2010 1992 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular Disease in Chronic Kidney Disease
    2021 1.1k citations Jürgen Floege et al. profile →
  2. The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
    2003 737 citations Jürgen Floege et al. Journal of Clinical Investigation profile →
  3. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study
    2003 736 citations Jürgen Floege et al. profile →
  4. Renal fibrosis: novel insights into mechanisms and therapeutic targets
    2010 507 citations Peter Boor, Tammo Ostendorf et al. profile →
  5. Renal injury from angiotensin II-mediated hypertension.
    1992 469 citations Jürgen Floege et al. profile →
  6. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
    2015 457 citations Frank Eitner, Christina Fitzner et al. profile →
  7. WNT–β-catenin signalling — a versatile player in kidney injury and repair
    2020 303 citations Jürgen Floege et al. profile →
  8. Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
    2023 121 citations Jürgen Floege, Vladimı́r Tesař et al. profile →
  9. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
    2024 120 citations Brad H. Rovin, Jürgen Floege et al. Kidney International profile →
  10. IgA nephropathy
    2023 81 citations Eleni Stamellou, Peter Boor et al. profile →
  11. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
    2024 51 citations Jürgen Floege, Bart Maes et al. Kidney International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Floege Germany 78 12.3k 4.5k 3.1k 2.8k 2.4k 412 21.0k
Ziad A. Massy France 69 11.5k 0.9× 3.6k 0.8× 2.9k 0.9× 3.9k 1.4× 1.4k 0.6× 440 21.9k
Alberto Ortíz Spain 85 9.8k 0.8× 8.7k 1.9× 3.1k 1.0× 3.8k 1.3× 2.6k 1.1× 847 28.9k
Yasuhiko Tomino Japan 57 11.0k 0.9× 3.7k 0.8× 2.5k 0.8× 2.4k 0.8× 2.4k 1.0× 626 19.7k
Kerstin Amann Germany 74 7.5k 0.6× 6.7k 1.5× 3.3k 1.1× 2.9k 1.0× 1.6k 0.6× 584 24.4k
Agnes B. Fogo United States 86 10.1k 0.8× 7.1k 1.6× 3.1k 1.0× 2.7k 0.9× 1.7k 0.7× 501 23.7k
Masaomi Nangaku Japan 82 8.4k 0.7× 6.9k 1.6× 2.3k 0.8× 2.5k 0.9× 1.5k 0.6× 712 24.1k
Prasad Devarajan United States 87 21.4k 1.7× 4.0k 0.9× 3.4k 1.1× 4.7k 1.6× 1.8k 0.7× 304 29.8k
Hirofumi Makino Japan 74 6.6k 0.5× 7.0k 1.6× 2.6k 0.8× 3.3k 1.2× 1.4k 0.6× 672 23.6k
Seiichi Matsuo Japan 60 6.9k 0.6× 3.1k 0.7× 2.7k 0.9× 2.9k 1.0× 1.3k 0.5× 321 17.7k
Danilo Fliser Germany 75 6.6k 0.5× 4.0k 0.9× 2.3k 0.7× 2.7k 1.0× 1.0k 0.4× 301 18.6k

Countries citing papers authored by Jürgen Floege

Since Specialization
Citations

This map shows the geographic impact of Jürgen Floege's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Floege with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Floege more than expected).

Fields of papers citing papers by Jürgen Floege

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Floege. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Floege. The network helps show where Jürgen Floege may publish in the future.

Co-authorship network of co-authors of Jürgen Floege

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Floege. A scholar is included among the top collaborators of Jürgen Floege based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Floege. Jürgen Floege is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yingying, Ina V. Martin, Ute Raffetseder, et al.. (2025). The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis. American Journal of Physiology-Renal Physiology. 329(4). F496–F509.
2.
3.
Murt, Ahmet, İlay Berke, Annette Bruchfeld, et al.. (2025). Malignancies and glomerulonephritis: when to suspect and when to screen?. Clinical Kidney Journal. 18(5). sfaf101–sfaf101. 2 indexed citations
4.
Bruchfeld, Annette, Fernando Caravaca‐Fontán, Gema Fernández‐Juárez, et al.. (2024). Immunoengineering for autoimmune-kidney disease. Nephrology Dialysis Transplantation. 39(12). 1934–1937. 1 indexed citations
5.
Steiger, Stefanie, Li Li, Annette Bruchfeld, et al.. (2024). Sex dimorphism in kidney health and disease: mechanistic insights and clinical implication. Kidney International. 107(1). 51–67. 5 indexed citations
6.
Larkin, John W., Suman Lama, Joanna Willetts, et al.. (2024). Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning. BMC Nephrology. 25(1). 366–366. 3 indexed citations
7.
Hölscher, David L., Nassim Bouteldja, María Luisa Russo, et al.. (2023). Next-Generation Morphometry for pathomics-data mining in histopathology. Nature Communications. 14(1). 470–470. 67 indexed citations
8.
Cattran, Daniel C., Jürgen Floege, & Rosanna Coppo. (2023). Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy. Kidney International Reports. 8(12). 2515–2528. 9 indexed citations
9.
Kolbrink, Benedikt, Katrin Schüssel, Friedrich Alexander von Samson‐Himmelstjerna, et al.. (2023). Patient-focused outcomes after initiation of dialysis for ESRD: mortality, hospitalization and functional impairment. Nephrology Dialysis Transplantation. 38(11). 2528–2536. 11 indexed citations
10.
Smeets, Bart, Eva Miriam Buhl, Marcus J. Moeller, et al.. (2022). The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 34(2). 241–257. 11 indexed citations
11.
Thompson, Aliza, Kevin Carroll, Lesley A. Inker, et al.. (2019). Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 14(3). 469–481. 161 indexed citations
12.
Sáez-Rodríguez, Julio, Markus M. Rinschen, Jürgen Floege, & Rafael Kramann. (2019). Big science and big data in nephrology. Kidney International. 95(6). 1326–1337. 46 indexed citations
13.
Socías, Antònia, et al.. (2016). Diferencias en los valores de procalcitonina en las bacteriemias por gram positivos y gram negativos en pacientes con sepsis grave y shock séptico. 31(2). 13–18.
14.
Rauen, Thomas, Frank Eitner, Christina Fitzner, & Jürgen Floege. (2016). Con: STOP immunosuppression in IgA nephropathy. Nephrology Dialysis Transplantation. 31(11). 1771–1774. 14 indexed citations
15.
Braun, Gerald S., Yuichi Maruta, Felix Heymann, et al.. (2015). IL-6 Trans-Signaling Drives Murine Crescentic GN. Journal of the American Society of Nephrology. 27(1). 132–142. 49 indexed citations
16.
Gammons, Melissa V., et al.. (2010). VEGF-A(165)b Is Cytoprotective and Antiangiogenic in the Retina. UCL Discovery (University College London). 1 indexed citations
17.
Eitner, Frank, Diana Ackermann, R.-D Hilgers, & Jürgen Floege. (2008). Supportive Versus Immunosuppressive Therapy of Progressive IgA Nephropathy (STOP) IgAN trial: rationale and study protocol. Journal of Nephrology. 21(3). 284–289. 54 indexed citations
18.
Boor, Peter, Andrzej Konieczny, Luisa L. Villa, et al.. (2007). PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrology Dialysis Transplantation. 22(5). 1323–1331. 52 indexed citations
19.
Eitner, Frank & Jürgen Floege. (2003). Novel insights into renal fibrosis. Current Opinion in Nephrology & Hypertension. 12(3). 227–232. 31 indexed citations
20.
Floege, Jürgen, Wilhelm Kriz, Matthias B. Schulze, et al.. (1995). Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.. Journal of Clinical Investigation. 96(6). 2809–2819. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziad A. Massy Breakdown of academic impact, for papers by Alberto Ortíz Breakdown of academic impact, for papers by Yasuhiko Tomino Breakdown of academic impact, for papers by Kerstin Amann Breakdown of academic impact, for papers by Agnes B. Fogo Breakdown of academic impact, for papers by Masaomi Nangaku Breakdown of academic impact, for papers by Prasad Devarajan Breakdown of academic impact, for papers by Hirofumi Makino Breakdown of academic impact, for papers by Seiichi Matsuo Breakdown of academic impact, for papers by Danilo Fliser
Rankless by CCL
2026